시장보고서

상품코드

1571739

바이오서저리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Biosurgery Market Size, Share & Trends Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), By Application (General Surgery, Orthopedic Surgery), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

바이오서저리 시장 성장과 동향:

그랜드뷰 리서치(Grandview Research)의 최신 보고서에 따르면, 세계 바이오서저리 시장 규모는 2030년까지 358억 5,000만 달러에 달할 것으로 예상됩니다.

이 시장은 2024년부터 2030년까지 연평균 4.7%의 성장률을 보일 것으로 예측됩니다. 다기능 제품의 가용성, 생활습관병, 비만, 스포츠 관련 부상의 확산으로 인한 수술 건수 증가 등의 요인이 성장을 촉진할 것으로 예측됩니다. 바이오서저리 제품은 유착, 상처 봉합, 손상된 뼈와 조직의 치유를 목적으로 하는 외과 수술에 사용됩니다.

바이오서저리 제품은 화상, 족부 궤양, 악성 상처, 감염된 수술 상처와 같은 만성 상처 치료에 사용됩니다. 또한, 과도한 출혈이 발생하기 쉬운 환자에서 혈액 응고 발생률이 증가함에 따라 시장 성장을 촉진할 것으로 예상됩니다. 또한, 출혈 관리 및 다양한 중증 외상에 대한 수요가 증가함에 따라 예측 기간 동안 바이오서저리 시장의 성장을 촉진할 것으로 예상됩니다.

당뇨병의 높은 유병률은 상처와 감염의 위험을 증가시켜 바이오 외과 제품에 대한 요구 사항을 만듭니다. American College of Physicians에 따르면 2017년 당뇨병 성 족부 궤양의 전 세계 연간 발생률은 6.3 %였습니다. 이 요인은 향후 몇 년 동안 제품 수요를 촉진할 것으로 예상됩니다. 또한, 다양한 만성 질환에 취약한 노인 인구의 증가는 시장을 촉진할 것으로 예상됩니다. 세계보건기구(WHO)에 따르면, 세계 고령화 인구는 2015년 9억 명에서 2050년 20억 명에 이를 것으로 예상됩니다. 정형외과, 신경외과, 부인과 수술과 같은 다른 수술에 바이오서저리를 적용하는 것이 시장을 견인할 것으로 예상됩니다.

바이오서저리 시장 보고서 하이라이트

외과용 실란트는 2023년 26.9%의 매출 점유율로 바이오서저리 시장을 장악했습니다. 이 부문의 성장은 주로 여러 가지 이유로 수행되는 수술 건수의 증가에 영향을 받았습니다.
2023년 바이오서저리 세계 산업은 일반 외과 수술 응용 부문이 지배적이었으며, 심혈관 수술 응용 부문은 2024년부터 2030년까지 가장 빠른 CAGR을 경험할 것으로 예상됩니다.
북미 바이오서저리 시장은 2023년 50.1%의 가장 큰 매출 점유율을 차지하며 세계 산업을 지배했습니다.
아시아태평양 바이오서저리 시장은 예측 기간 동안 6.0%의 가장 빠른 CAGR을 보일 것으로 예상됩니다. 이러한 성장률은 중국과 인도와 같은 국가의 급속한 경제 성장, 가처분 소득 수준 증가, 의료 인프라 증가에 기인합니다.

바이오서저리 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제7장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Sanofi
- Baxter
- INTEGRA LIFESCIENCES
- Medtronic
- B. Braun SE
- Pfizer Inc
- Stryker
- Johnson & Johnson Services, Inc
- BD
- Artivion, Inc(CryoLife, Inc.)

ksm 24.11.01

Biosurgery Market Growth & Trends:

The global biosurgery market size is anticipated to reach USD 35.85 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 4.7% from 2024 to 2030. Factors such as the availability of multifunctional products and increasing number of surgeries due to prevalence of lifestyle related disease, obesity, and sports related injuries are projected to drive the growth. Biosurgery products are used in surgical procedures for adhesion or wound sealing and healing damaged bones and tissues.

Biosurgery products are used for the treatment of chronic wounds, such as burns, foot ulcer, malignant wounds, and infected surgical wounds. Furthermore, increasing incidence of blood clotting among patients prone to excessive blood loss is expected to drive the market growth. Moreover, rising need for blood loss management and various severe trauma injuries is expected to drive the growth of biosurgery market over the forecast period.

High prevalence of diabetes increases the risk of wounds and infections, creating requirement for biosurgery products. According to the American College of Physicians, the global annual incidence of diabetic foot ulcer was 6.3% in 2017. This factor is projected to drive the product demand in the forthcoming years. Moreover, rising geriatric population prone to various chronic diseases is expected to propel the market. According to the World Health Organization (WHO), the global aging population is expected to reach 2 billion by 2050, from 900 million in 2015. Application of biosurgery in other surgical procedures, such as orthopedic, neurological, and gynecology surgeries is expected to drive the market.

Biosurgery Market Report Highlights:

Surgical sealants dominated the biosurgery market with a revenue share of 26.9% in 2023. The growth of this segment is primarily influenced by the growing number of surgeries performed for various reasons.
The general surgery application segment dominated the global industry for biosurgery in 2023 and the cardiovascular surgery application segment is expected to experience the fastest CAGR from 2024 to 2030.
North America biosurgery market dominated the global industry and accounted for the largest revenue share of 50.1% in 2023.
The Asia-Pacific biosurgery market is anticipated to witness the fastest CAGR of 6.0% during the forecast period. The projected growth rate is attributed to rapid economic growth in countries such as China and India, increasing disposable income levels, and rising healthcare infrastructure.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Biosurgery Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Biosurgery Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Biosurgery Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Surgical sealants
- 4.3.1. Surgical sealants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Hemostatic agents
- 4.4.1. Hemostatic agents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Adhesion barriers
- 4.5.1. Adhesion barriers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.6. Soft Tissue Attachments
- 4.6.1. Soft Tissue Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.7. Bone graft Attachments
- 4.7.1. Bone graft Attachments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.8. Others
- 4.8.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Biosurgery Market: Application Movement Analysis, 2023 & 2030 (USD Million)
5.3. General surgery
- 5.3.1. General surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Orthopedic surgery
- 5.4.1. Orthopedic surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Cardiovascular surgery
- 5.5.1. Cardiovascular surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Neurological surgery
- 5.6.1. Neurological surgery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Others
- 5.7.1. Others Supplements Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis

6.1. Biosurgery Market Share, By Region, 2023 & 2030 (USD Million)
6.2. North America
- 6.2.1. North America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.2. U.S.
  - 6.2.2.1. U.S. Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.3. Canada
  - 6.2.3.1. Canada Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.2.4. Mexico
  - 6.2.4.1. Mexico Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.3. Europe
- 6.3.1. Europe Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.2. UK
  - 6.3.2.1. UK Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.3. Germany
  - 6.3.3.1. Germany Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.4. France
  - 6.3.4.1. France Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.5. Italy
  - 6.3.5.1. Italy Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.6. Spain
  - 6.3.6.1. Spain Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.7. Denmark
  - 6.3.7.1. Denmark Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.8. Sweden
  - 6.3.8.1. Sweden Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.3.9. Norway
  - 6.3.9.1. Norway Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Asia Pacific
- 6.4.1. Asia Pacific Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.2. Japan
  - 6.4.2.1. Japan Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.3. China
  - 6.4.3.2. China Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.4. India
  - 6.4.4.1. India Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.5. Australia
  - 6.4.5.1. Australia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.6. South Korea
  - 6.4.6.1. South Korea Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.4.7. Thailand
  - 6.4.7.1. Thailand Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Latin America
- 6.5.1. Latin America Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.2. Brazil
  - 6.5.2.1. Brazil Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.5.3. Argentina
  - 6.5.3.1. Argentina Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
6.6. Middle East & Africa
- 6.6.1. MEA Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.2. South Africa
  - 6.6.2.1. South Africa Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.3. Saudi Arabia
  - 6.6.3.1. Saudi Arabia Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.4. UAE
  - 6.6.4.1. UAE Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 6.6.5. Kuwait
  - 6.6.5.1. Kuwait Biosurgery Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

7.1. Recent Developments & Impact Analysis by Key Market Participants
7.2. Company Categorization
7.3. Company Heat Map Analysis
7.4. Company Profiles
- 7.4.1. Sanofi
  - 7.4.1.1. Participant's Overview
  - 7.4.1.2. Financial Performance
  - 7.4.1.3. Product Benchmarking
  - 7.4.1.4. Recent Developments/ Strategic Initiatives
  - 7.4.1.5. Strategic Initiatives
- 7.4.2. Baxter
  - 7.4.2.1. Participant's Overview
  - 7.4.2.2. Financial Performance
  - 7.4.2.3. Product Benchmarking
  - 7.4.2.4. Recent Developments/ Strategic Initiatives
  - 7.4.2.5. Strategic Initiatives
- 7.4.3. INTEGRA LIFESCIENCES
  - 7.4.3.1. Participant's Overview
  - 7.4.3.2. Financial Performance
  - 7.4.3.3. Product Benchmarking
  - 7.4.3.4. Recent Developments/ Strategic Initiatives
  - 7.4.3.5. Strategic Initiatives
- 7.4.4. Medtronic
  - 7.4.4.1. Participant's Overview
  - 7.4.4.2. Financial Performance
  - 7.4.4.3. Product Benchmarking
  - 7.4.4.4. Recent Developments/ Strategic Initiatives
  - 7.4.4.5. Strategic Initiatives
- 7.4.5. B. Braun SE
  - 7.4.5.1. Participant's Overview
  - 7.4.5.2. Financial Performance
  - 7.4.5.3. Product Benchmarking
  - 7.4.5.4. Recent Developments/ Strategic Initiatives
  - 7.4.5.5. Strategic Initiatives
- 7.4.6. Pfizer Inc
  - 7.4.6.1. Participant's Overview
  - 7.4.6.2. Financial Performance
  - 7.4.6.3. Product Benchmarking
  - 7.4.6.4. Recent Developments/ Strategic Initiatives
  - 7.4.6.5. Strategic Initiatives
- 7.4.7. Stryker
  - 7.4.7.1. Participant's Overview
  - 7.4.7.2. Financial Performance
  - 7.4.7.3. Product Benchmarking
  - 7.4.7.4. Recent Developments/ Strategic Initiatives
  - 7.4.7.5. Strategic Initiatives
- 7.4.8. Johnson & Johnson Services, Inc
  - 7.4.8.1. Participant's Overview
  - 7.4.8.2. Financial Performance
  - 7.4.8.3. Product Benchmarking
  - 7.4.8.4. Recent Developments/ Strategic Initiatives
  - 7.4.8.5. Strategic Initiatives
- 7.4.9. BD
  - 7.4.9.1. Participant's Overview
  - 7.4.9.2. Financial Performance
  - 7.4.9.3. Product Benchmarking
  - 7.4.9.4. Recent Developments/ Strategic Initiatives
  - 7.4.9.5. Strategic Initiatives
- 7.4.10. Artivion, Inc (CryoLife, Inc.)
  - 7.4.10.1. Participant's Overview
  - 7.4.10.2. Financial Performance
  - 7.4.10.3. Product Benchmarking
  - 7.4.10.4. Recent Developments/ Strategic Initiatives
  - 7.4.10.5. Strategic Initiatives

바이오서저리 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Biosurgery Market Size, Share & Trends Analysis Report By Product (Surgical Sealants, Hemostatic Agents, Adhesion Barriers, Soft Tissue Attachments), By Application (General Surgery, Orthopedic Surgery), By Region, And Segment Forecasts, 2024 - 2030

바이오서저리 시장 성장과 동향:

바이오서저리 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 바이오서저리 시장 변수, 동향, 범위

제4장 바이오서저리 시장 : 제품 추정·동향 분석

제5장 바이오서저리 시장 : 용도 추정·동향 분석

제6장 바이오서저리 시장 : 지역 추정·동향 분석